Richard, OPEN MOUTH, INSERT FOOT. Looks like you're the ignorant one. And you even had 1 1/2 days to read over this article...in fact, looks like you didn't even get past the FIRST sentence of the company press release. By the way, meningitis, which is the Phase 3 you're referring to, is NOT the common cold.
Tuesday July 13, 5:30 am Eastern Time
Company Press Release
SOURCE: ViroPharma Incorporated
ViroPharma Announces Successful Viral Respiratory Infection Program With Pleconaril
First Clinical Effect Seen in Patients With Severe Common Cold
EXTON, Pa., July 13 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM - news) today announced results from its Phase 2 program with pleconaril to treat patients with viral respiratory infection (VRI), a severe form of the common cold. Trial results indicated that pleconaril-treated patients experienced a clinically and statistically significant reduction in time to complete resolution of all disease symptoms, as well as a reduction in the patient- reported time to returning to feeling normal, as measured by a global assessment score. |
